β-amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wong, Bruce X ^a   Tsatsanis, Andrew ^b   Lim, Linh Q ^a   Adlard, Paul A ^a   Bush, Ashley I ^a   Duce, James A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CERULOPLASMIN; FERROPORTIN; PHOSPHATE; CATION TRANSPORT PROTEIN; METAL TRANSPORTING PROTEIN 1;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRON METABOLISM; IRON TRANSPORT; MOUSE; NERVE CELL; NONHUMAN; OXIDATION; PROTEIN FUNCTION; PROTEIN STABILITY; ANIMAL; HEK293 CELL LINE; METABOLISM; OXIDATION REDUCTION REACTION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CATION TRANSPORT PROTEINS; CERULOPLASMIN; HEK293 CELLS; HUMANS; MICE; OXIDATION-REDUCTION;

EID: 84914693430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114174     Document Type: Article

References (55)

1. Caldwell JH, Klevanski M, Saar M, Muller UC (2013) Roles of the amyloid precursor protein family in the peripheral nervous system. Mech Dev 130: 433-446.
2. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142: 857-867.
3. Waldron KJ, Rutherford JC, Ford D, Robinson NJ (2009) Metalloproteins and metal sensing. Nature 460: 823-830.
4. Haber F, Weiss J (1934) The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc London, Ser A 147: 332-351.
5. Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc, Trans 65: 899-911.
6. Davies KJ (1987) Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem 262: 9895-9901.
7. Wong BX, Duce JA (2014) The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders. Front Pharmacol 5: 81.
8. Crichton RR (2009) Inorganic Biochemistry of Iron Metabolism: From molecular mechanisms to clinical consequences. Chichester, UK: John Wiley & Sons, Ltd.
9. Nevo Y, Nelson N (2006) The NRAMP family of metal-ion transporters. Biochim Biophys Acta 1763: 609-620.
10. Jandl JH, Katz JH (1963) The plasma-to-cell cycle of transferrin. J Clin Invest 42: 314-326.
11. Pinilla-Tenas JJ, Sparkman BK, Shawki A, Illing AC, Mitchell CJ, et al. (2011) Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. Am J Physiol Cell Physiol 301: C862-871.
12. Schulz K, Vulpe CD, Harris LZ, David S (2011) Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci 31: 13301-13311.
13. Yeh KY, Yeh M, Glass J (2011) Interactions between ferroportin and hephaestin in rat enterocytes are reduced after iron ingestion. Gastroenterology 141: 292-299.
14. De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, et al. (2007) Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26: 2823-2831.
15. Wan L, Nie G, Zhang J, Zhao B (2012) Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells. J Alzheimers Dis 30: 523-530.
16. Wan L, Nie G, Zhang J, Luo Y, Zhang P, et al. (2011) beta-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 50: 122-129.
17. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, et al. (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18: 291-295.
18. Needham BE, Ciccotosto GD, Cappai R (2014) Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis. Metallomics 6: 598-603.
19. McCarthy RC, Park YH, Kosman DJ (2014) sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep 15: 809-815.
20. Honarmand Ebrahimi K, Dienemann C, Hoefgen S, Than ME, Hagedoorn PL, et al. (2013) The amyloid precursor protein (APP) does not have a ferroxidase site in its E2 domain. PLoS One 8: e72177.
21. Ebrahimi KH, Hagedoorn PL, Hagen WR (2012) A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron. PLoS One 7: e40287.
22. Wong BX, Ayton S, Lam LQ, Lei P, Adlard PA, et al. (2014) A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe under physiologically relevant conditions. Biochim Biophys Acta 1840: 3299-3310.
23. Hruska KA, Mathew S (2011) The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Adv Chronic Kidney Dis 18: 98-104.
24. Guerreiro PM, Bataille AM, Parker SL, Renfro JL (2014) Active removal of inorganic phosphate from cerebrospinal fluid by the choroid plexus. Am J Physiol Renal Physiol 306: F1275-1284.
25. Weiss G, Schett G (2013) Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol 9: 205-215.
26. Henry A, Masters CL, Beyreuther K, Cappai R (1997) Expression of human amyloid precursor protein ectodomains in Pichia pastoris: analysis of culture conditions, purification, and characterization. Protein Expr Purif 10: 283-291.
27. Erel O (1998) Automated measurement of serum ferroxidase activity. Clin Chem 44: 2313-2319.
28. Minotti G, Ikeda-Saito M (1992) Fe(II) oxidation and Fe(III) incorporation by the M(r) 66,000 microsomal iron protein that stimulates NADPH oxidation. J Biol Chem 267: 7611-7614.
29. Johnson DA, Osaki S, Frieden E (1967) A micromethod for the determination of ferroxidase (ceruloplasmin) in human serums. Clin Chem 13: 142-150.
30. White AR, Zheng H, Galatis D, Maher F, Hesse L, et al. (1998) Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress. J Neurosci 18: 6207-6217.
31. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, et al. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96: 3922-3927.
32. Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, et al. (2004) Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001: 108-117.
33. Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, et al. (1996) Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 271: 22908-22914.
34. Hilbich C, Monning U, Grund C, Masters CL, Beyreuther K (1993) Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 268: 26571-26577.
35. Gralle M, Botelho MM, de Oliveira CL, Torriani I, Ferreira ST (2002) Solution studies and structural model of the extracellular domain of the human amyloid precursor protein. Biophys J 83: 3513-3524.
36. Guillot-Sestier MV, Sunyach C, Ferreira ST, Marzolo MP, Bauer C, et al. (2012) alpha-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid beta (Abeta)-associated cell death. J Biol Chem 287: 5021-5032.
37. Wong BX, Ayton S, Lam LQ, Lei P, Adlard PA, et al. (2014) A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of iron under physiologically relevant conditions. BBA In Press.
38. Harris WR (2012) Anion binding properties of the transferrins. Implications for function. Biochim Biophys Acta 1820: 348-361.
39. Kosman DJ (2013) Iron metabolism in aerobes: managing ferric iron hydrolysis and ferrous iron autoxidation. Coord Chem Rev 257: 210-217.
40. Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M (2003) Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102: 4191-4197.
41. Yang F, Wang X, Haile DJ, Piantadosi CA, Ghio AJ (2002) Iron increases expression of iron-export protein MTP1 in lung cells. Am J Physiol Lung Cell Mol Physiol 283: L932-939.
42. Aisen P, Aasa R, Malmstrom BG, Vanngard T (1967) Bicarbonate and the binding of iron to transferrin. J Biol Chem 242: 2484-2490.
43. Hilton RJ, Seare MC, Andros ND, Kenealey Z, Orozco CM, et al. (2012) Phosphate inhibits in vitro Fe3+ loading into transferrin by forming a soluble Fe(III)-phosphate complex: a potential non-transferrin bound iron species. J Inorg Biochem 110: 1-7.
44. Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, et al. (2011) Iron modifies plasma FGF23 xdifferently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 96: 3541-3549.
45. Gordeuk VR, Prithviraj P, Dolinar T, Brittenham GM (1988) Interleukin 1 administration in mice produces hypoferremia despite neutropenia. J Clin Invest 82: 1934-1938.
46. Cahill CM, Lahiri DK, Huang X, Rogers JT (2009) Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta 1790: 615-628.
47. Van Nostrand WE, Wagner SL, Shankle WR, Farrow JS, Dick M, et al. (1992) Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci U S A 89: 2551-2555.
48. Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, et al. (1994) In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15: 1129-1138.
49. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 27: 595-611.
50. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, et al. (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22: 6578-6586.
51. Castellani RJ, Honda K, Zhu X, Cash AD, Nunomura A, et al. (2004) Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res Rev 3: 319-326.
52. Honda K, Casadesus G, Petersen RB, Perry G, Smith MA (2004) Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci 1012: 179-182.
53. Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, et al. (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 73: 554-559.
54. Yoshida K, Kaneko K, Miyajima H, Tokuda T, Nakamura A, et al. (2000) Increased lipid peroxidation in the brains of aceruloplasminemia patients. J Neurol Sci 175: 91-95.
55. Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, et al. (2002) Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 36: 303-306.